Dr. Darren Christopher Spearman, MD

Dr. Spearman practices at Gastroenterology Consultants of San Antonio - Northeast Clinic and Ambulatory Surgical Center in Live Oak, Texas.

Dr. Spearman's NPI, 1851323034, was assigned on July 7, 2006. Dr. Spearman graduated from Uniformed Services University, F. Edward Hebert School of Medicine in 2004. Dr. Spearman's Texas license number on file is Q9519.

Dr. Spearman's primary practice is Gastroenterology Consultants of San Antonio - Northeast Clinic and Ambulatory Surgical Center, at 12850 Toepperwein Rd, Live Oak, TX 78233. The practice phone is (210) 614-1234.

Dr. Spearman's primary practice is Gastroenterology Consultants of San Antonio - Northeast Clinic and Ambulatory Surgical Center in Live Oak, Texas. Dr. Spearman is also affiliated with Methodist Hospital. The medical group on file is Texas Digestive Disease Consultants. Dmand AI also links Dr. Spearman to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Spearman practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Spearman's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Spearman is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Spearman's licenses on file in 3 states: Texas, North Dakota and Virginia.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver, gastroduodenitis, gastroenteritis and gastrointestinal bleeding among the conditions Dr. Spearman treats.

CMS data shows 825 Medicare services from Dr. Spearman across 12 procedure codes in 2024, for 525 Medicare patients. Medicare paid $95,625 for them.

CMS counts 525 Medicare patients who saw Dr. Spearman in 2024. The largest group is 65 to 74, with 325 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.00, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Spearman's median patient age at 61, with 55% women.

In 2024, Dr. Spearman wrote 1,015 Medicare Part D claims for 411 patients. 63% of them were for generic drugs. CMS names the drug for 833 of them, across 20 drugs with 11 or more claims each, at $290,939 in total drug cost. In 2023, CMS named 622 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Spearman for performance year 2024, reported as part of a group. Dr. Spearman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 171 procedures of colonoscopy by Dr. Spearman, more than 91% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Spearman in 2016. Dr. Spearman's most frequent co-author is Alexander W. Brown, MD.

Dmand AI links Dr. Spearman to 2 clinical trials, 2 of them phase 3 studies. Conditions studied include Eosinophilic Esophagitis and Esophagitis. Shire sponsors the most, 2.

CMS Open Payments shows 544 general payments to Dr. Spearman from 38 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Abbvie Inc. paid the most, $2,942.

Dr. Spearman graduated from Uniformed Services University, F. Edward Hebert School of Medicine in 2004.

Dr. Spearman is in network with 22 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.